国家重点监控药品处方(医嘱)审核点评规则  

Review and comment rules of national key monitoring drug prescriptions(medical orders)

作　　者：阳柳 韩勇[1,2] 申青 周逸梦[1,2] 任为 闫峻峰 童荣生 YANG Liu;HAN Yong;SHEN Qing;ZHOU Yimeng;REN Wei;YAN Junfeng;TONG Rongsheng(Dept.of Pharmacy,Sichuan Academy of Medical Sciences·Sichuan Provincial People’s Hospital,Chengdu 610072,China;Sichuan Provincial Key Laboratory of Personalized Drug Therapy,the Affiliated Hospital of UESTC,Chengdu 610072,China)

机构地区：[1]四川省医学科学院·四川省人民医院药学部,成都610072 [2]电子科技大学医学院个体化药物治疗四川省重点实验室,成都610072

出　　处：《中国药房》2023年第21期2561-2577,共17页China Pharmacy

基　　金：国家重点研发计划主动健康和老龄化科技应对重点专项(No.2020YFC2005500);四川省自然科学基金项目(No.2022NSFSC0818);个体化药物治疗四川省重点实验室开放课题(No.2021ZD01)。

摘　　要：为规范各级医疗机构对国家重点监控药品处方(医嘱)的审核点评工作,由四川省医学科学院·四川省人民医院牵头,根据国家卫生健康委于2023年1月13日确定的《第二批国家重点监控合理用药药品目录》(以下简称《目录》),组织编写了《国家重点监控药品处方(医嘱)审核点评规则》(以下简称《规则》)。编写组依据国家药品监督管理部门发布的法律法规及药品说明书、临床指南、专家共识等文献资料,结合患者的实际情况(包括年龄、体重和肝肾功能等因素),对《目录》中30种药品的常见不合理用药问题进行分类,并制定审核点评细则,经过2轮德尔菲法线上问卷调查,并通过2次专家线上会议充分讨论后经指导委员会审核,形成最终《规则》。本《规则》旨在为医疗机构开展《目录》中药品的合理用药评价提供参考,进而实现国家重点监控药品的规范化管理,促进医疗机构合理用药,保障患者用药安全。In order to standardize the review and comment of national key monitoring drug prescriptions(medical orders) by medical institutions at all levels,the Sichuan Academy of Medical Sciences·Sichuan Provincial People's Hospital took the lead in compiling the Review and Comment Rules of National Key Monitoring Drugs prescriptions(Medical Orders) herein after referred to as the Rules in accordance with the Second Batch of National Key Monitoring Rational Drug Use List(hereinafter referred to as the List) issued by the National Health Commission confirmed in Jan.13,2023.According to the laws and drug instructions issued by the national drug regulatory department,clinical guidelines and expert consensus,combined with the actual situation of patients(including age,body weight,liver and kidney function),the writing group classified the common and unreasonable drug use problems for 30 kinds of drugs included in the List and develop the review and comment details.After two rounds of Delphi method questionnaire research and experts' online meetings,and reviewed by the steering committee,the final Rules was formed.The Rules aim to provide reference for the evaluation of the rational use of drugs included in the List by medical institutions,so as to realize the standardized management of key monitoring drugs,promote the rational drug use in medical institutions,and ensure the safety of drug use for patients.

关 键 词：重点监控药品 合理用药 审核点评规则 医疗机构 

分 类 号：R95[医药卫生—药学]